The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease

Vedolizumab is a humanized monoclonal α4β7 integrin antibody used in patients with Crohn’s disease (CD) and ulcerative colitis (UC). Limited data are available on the use of vedolizumab in patients with concurrent cirrhosis and inflammatory bowel disease (IBD). Patients with cirrhosis are unique, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapila, Nikhil, Flocco, Gianina, Shen, Bo, Modaresi Esfeh, Jamak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168050/
https://www.ncbi.nlm.nih.gov/pubmed/30305988
http://dx.doi.org/10.7759/cureus.3080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168050/
https://www.ncbi.nlm.nih.gov/pubmed/30305988
http://dx.doi.org/10.7759/cureus.3080

Ejemplares similares